Strueber, M <br/><br/>
Everolimus Versus Mycophenolate Mofetil De Novo After Lung Transplantation: A Prospective, Randomized, Open-Label Trial.  [electronic resource] 

 -  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons  11 2016 
 - 3171-3180 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-6143 
<br/><br/><label>Standard No.: </label>10.1111/ajt.13835  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antibiotics, Antineoplastic--pharmacology<br/>Everolimus--pharmacology<br/>Female<br/>Follow-Up Studies<br/>Graft Rejection--drug therapy<br/>Graft Survival--drug effects<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Lung Diseases--surgery<br/>Lung Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Mycophenolic Acid--pharmacology<br/>Postoperative Complications--drug therapy<br/>Prognosis<br/>Prospective Studies<br/>Risk Factors<br/>Young Adult